Kristin D Gerson1, Nancy Yang2, Lauren Anton2, Maayan Levy3, Jacques Ravel4, Michal A Elovitz5, Heather H Burris6. 1. Center for Research on Reproduction and Women's Health, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. Electronic address: kristin.gerson@pennmedicine.upenn.edu. 2. Center for Research on Reproduction and Women's Health, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. 3. Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. 4. Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD. 5. Center for Research on Reproduction and Women's Health, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. 6. Center for Research on Reproduction and Women's Health, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Children's Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Abstract
BACKGROUND: A short cervix is a risk factor for preterm birth. The molecular drivers of a short cervix remain elusive. Metabolites may function as mediators of pathologic processes. OBJECTIVE: We sought to determine if a distinct cervicovaginal metabolomic profile is associated with a short cervix (<25 mm) to unveil the potential mechanisms by which premature cervical remodeling leads to a short cervix. STUDY DESIGN: This was a secondary analysis of a completed prospective pregnancy cohort. Cervicovaginal fluid was obtained between 20 and 24 weeks' gestation. The participants selected for metabolomic profiling were frequency-matched by birth outcome and cervicovaginal microbiota profile. This analysis included 222 participants with cervical length measured. A short cervix was defined as one having length <25 mm, as measured by transvaginal ultrasound. Unpaired t-tests were performed with a Bonferroni correction for multiple comparisons. RESULTS: There were 27 participants with a short cervix, and 195 with normal cervical length. Of the 637 metabolites detected, 26 differed between those with a short cervix and those with normal cervical lengths; 22 were decreased, of which 21 belonged to the lipid metabolism pathway (all P<.000079). Diethanolamine, erythritol, progesterone, and mannitol or sorbitol were increased in the cases of short cervix. Among participants with Lactobacillus-deficient microbiota, only diethanolamine and mannitol or sorbitol differed between short cervix (n=17) and normal cervical length (n=75), both increased. CONCLUSION: A short cervix is associated with decreased cervicovaginal lipid metabolites, particularly sphingolipids. This class of lipids stabilizes cell membranes and protects against environmental exposures. Increased diethanolamine-an immunostimulatory xenobiotic-is associated with a short cervix. These observations begin to identify the potential mechanisms by which modifiable environmental factors may invoke cell damage in the setting of biological vulnerability, thus promoting premature cervical remodeling in spontaneous preterm birth.
BACKGROUND: A short cervix is a risk factor for preterm birth. The molecular drivers of a short cervix remain elusive. Metabolites may function as mediators of pathologic processes. OBJECTIVE: We sought to determine if a distinct cervicovaginal metabolomic profile is associated with a short cervix (<25 mm) to unveil the potential mechanisms by which premature cervical remodeling leads to a short cervix. STUDY DESIGN: This was a secondary analysis of a completed prospective pregnancy cohort. Cervicovaginal fluid was obtained between 20 and 24 weeks' gestation. The participants selected for metabolomic profiling were frequency-matched by birth outcome and cervicovaginal microbiota profile. This analysis included 222 participants with cervical length measured. A short cervix was defined as one having length <25 mm, as measured by transvaginal ultrasound. Unpaired t-tests were performed with a Bonferroni correction for multiple comparisons. RESULTS: There were 27 participants with a short cervix, and 195 with normal cervical length. Of the 637 metabolites detected, 26 differed between those with a short cervix and those with normal cervical lengths; 22 were decreased, of which 21 belonged to the lipid metabolism pathway (all P<.000079). Diethanolamine, erythritol, progesterone, and mannitol or sorbitol were increased in the cases of short cervix. Among participants with Lactobacillus-deficient microbiota, only diethanolamine and mannitol or sorbitol differed between short cervix (n=17) and normal cervical length (n=75), both increased. CONCLUSION: A short cervix is associated with decreased cervicovaginal lipid metabolites, particularly sphingolipids. This class of lipids stabilizes cell membranes and protects against environmental exposures. Increased diethanolamine-an immunostimulatory xenobiotic-is associated with a short cervix. These observations begin to identify the potential mechanisms by which modifiable environmental factors may invoke cell damage in the setting of biological vulnerability, thus promoting premature cervical remodeling in spontaneous preterm birth.
Authors: Benjamin J Callahan; Daniel B DiGiulio; Daniela S Aliaga Goltsman; Christine L Sun; Elizabeth K Costello; Pratheepa Jeganathan; Joseph R Biggio; Ronald J Wong; Maurice L Druzin; Gary M Shaw; David K Stevenson; Susan P Holmes; David A Relman Journal: Proc Natl Acad Sci U S A Date: 2017-08-28 Impact factor: 11.205
Authors: Lisa Ford; Adam D Kennedy; Kelli D Goodman; Kirk L Pappan; Anne M Evans; Luke A D Miller; Jacob E Wulff; Bobby R Wiggs; John J Lennon; Sarah Elsea; Douglas R Toal Journal: J Appl Lab Med Date: 2020-03-01
Authors: Richard G Brown; Julian R Marchesi; Yun S Lee; Ann Smith; Benjamin Lehne; Lindsay M Kindinger; Vasso Terzidou; Elaine Holmes; Jeremy K Nicholson; Phillip R Bennett; David A MacIntyre Journal: BMC Med Date: 2018-01-24 Impact factor: 8.775
Authors: Jennifer M Fettweis; Myrna G Serrano; J Paul Brooks; David J Edwards; Philippe H Girerd; Hardik I Parikh; Bernice Huang; Tom J Arodz; Laahirie Edupuganti; Abigail L Glascock; Jie Xu; Nicole R Jimenez; Stephany C Vivadelli; Stephen S Fong; Nihar U Sheth; Sophonie Jean; Vladimir Lee; Yahya A Bokhari; Ana M Lara; Shreni D Mistry; Robert A Duckworth; Steven P Bradley; Vishal N Koparde; X Valentine Orenda; Sarah H Milton; Sarah K Rozycki; Andrey V Matveyev; Michelle L Wright; Snehalata V Huzurbazar; Eugenie M Jackson; Ekaterina Smirnova; Jonas Korlach; Yu-Chih Tsai; Molly R Dickinson; Jamie L Brooks; Jennifer I Drake; Donald O Chaffin; Amber L Sexton; Michael G Gravett; Craig E Rubens; N Romesh Wijesooriya; Karen D Hendricks-Muñoz; Kimberly K Jefferson; Jerome F Strauss; Gregory A Buck Journal: Nat Med Date: 2019-05-29 Impact factor: 53.440
Authors: Kristin D Gerson; Lauren Anton; Briana Ferguson; Jacques Ravel; Heather H Burris; Michal A Elovitz Journal: J Reprod Immunol Date: 2022-05-23 Impact factor: 3.993